Press releases
- Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
- Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
- Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
- Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting
- AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
- Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
- Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
- U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
- Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food
- Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
More ▼
Key statistics
On Wednesday, Takeda Pharmaceutical Co Ltd (TKD:DUS) closed at 24.63, 3.14% above its 52-week low of 23.88, set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.70 |
---|---|
High | 24.76 |
Low | 24.63 |
Bid | -- |
Offer | -- |
Previous close | 24.63 |
Average volume | 246.00 |
---|---|
Shares outstanding | 1.58bn |
Free float | 1.58bn |
P/E (TTM) | 44.98 |
Market cap | 6.49tn JPY |
EPS (TTM) | 91.21 JPY |
Annual div (ADY) | 1.15 EUR |
---|---|
Annual div yield (ADY) | 4.71% |
Div ex-date | Mar 28 2024 |
Div pay-date | Jun 27 2024 |
Data delayed at least 15 minutes, as of Jun 05 2024 18:30 BST.
More ▼